These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 393526

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney.
    Schwertschlag U, Stahl T, Hackenthal E.
    Prostaglandins; 1982 Jan; 23(1):129-38. PubMed ID: 7038776
    [Abstract] [Full Text] [Related]

  • 3. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
    Miller OV, Aiken JW, Shebuski RJ, Gorman RR.
    Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
    Whittle BJ, Moncada S, Vane JR.
    Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
    [Abstract] [Full Text] [Related]

  • 5. The effect of 6-oxo-prostaglandin E1 on human platelet aggregation in whole blood in-vitro.
    Wilsoncroft PS, Lofts FJ, Griffiths RJ, Moore PK.
    J Pharm Pharmacol; 1985 Feb; 37(2):139-41. PubMed ID: 2858551
    [Abstract] [Full Text] [Related]

  • 6. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.
    Wong PY, Lee WH, Chao PH, Reiss RF, McGiff JC.
    J Biol Chem; 1980 Oct 10; 255(19):9021-4. PubMed ID: 6997309
    [Abstract] [Full Text] [Related]

  • 7. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S, Westwick J, Kakkar VV.
    Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666
    [Abstract] [Full Text] [Related]

  • 8. Prostanoids and hemostasis in chickens: anti-aggregating activity of prostaglandins E1 and E2, but not of prostacyclin and prostaglandin D2.
    Bult H, Wechsung E, Houvenaghel A, Herman AG.
    Prostaglandins; 1981 Jun 01; 21(6):1045-58. PubMed ID: 7027319
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Refractoriness of diabetic platelets to inhibitory prostaglandins.
    Lagarde M, Berciaud P, Burtin M, Dechavanne M.
    Prostaglandins Med; 1981 Oct 01; 7(4):341-7. PubMed ID: 6273957
    [Abstract] [Full Text] [Related]

  • 12. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ, Velders AJ, Karliczek GF, Homan van der Heide JN, Wildevuur CR.
    Trans Am Soc Artif Intern Organs; 1980 Oct 01; 26():481-6. PubMed ID: 7018057
    [No Abstract] [Full Text] [Related]

  • 13. Prostaglandin-related renin release from rabbit renal cortical slices.
    Spokas EG, Wong PY, McGiff JC.
    Hypertension; 1982 Oct 01; 4(3 Pt 2):96-100. PubMed ID: 7040243
    [Abstract] [Full Text] [Related]

  • 14. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
    Miyamori I, Morise T, Yasuhara S, Takeda Y, Koshida H, Takeda R.
    Br J Clin Pharmacol; 1985 Dec 01; 20(6):681-3. PubMed ID: 3912001
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 6-Keto-prostaglandin E1: its formation by platelets from prostacyclin and resistance to pulmonary degradation.
    Berry CN, Hoult JR.
    Pharmacology; 1983 Dec 01; 26(6):324-30. PubMed ID: 6348806
    [Abstract] [Full Text] [Related]

  • 17. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
    Ubatuba FB, Moncada S, Vane JR.
    Thromb Haemost; 1979 Apr 23; 41(2):425-35. PubMed ID: 382434
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes.
    Rao GH, Reddy KR, White JG.
    Prostaglandins Med; 1980 Jun 23; 4(6):385-97. PubMed ID: 6251492
    [Abstract] [Full Text] [Related]

  • 20. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
    Griffiths RJ, Moore PK.
    Br J Pharmacol; 1983 Oct 23; 80(2):395-402. PubMed ID: 6360281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.